ELI LILLY & Co
A research-based company that develops and sells pharmaceutical products.
LLY | US
Overview
Corporate Details
- ISIN(s):
- US5324571083
- LEI:
- Country:
- United States of America
- Address:
- LILLY CORPORATE CTR, 46285 INDIANAPOLIS
- Website:
- https://www.lilly.com/
- Sector:
- Manufacturing
Description
Eli Lilly and Company is a global, research-based medicine company that discovers, develops, manufactures, and sells pharmaceutical products. The company focuses on creating treatments in key therapeutic areas, including diabetes, obesity, immunology, oncology, and neuroscience. Leveraging biotechnology and chemistry, it develops medicines for some of the world's most significant health challenges. Historically known for the commercialization of insulin, the company continues to be a major provider of therapies for chronic diseases. Its stated purpose is to unite caring with discovery to create medicines that make life better for people around the world.
Unlock This Filing & Millions More
You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.
Filings
| Date | Filing | Language | Size | Actions | |
|---|---|---|---|---|---|
| 2018-11-06 14:54 |
Eli Lilly and Company: Eli Lilly and Company Files Form 8-K
|
English | 11.7 KB | ||
| 2018-11-06 12:33 |
Eli Lilly and Company: Lilly Delivers Solid Third-Quarter 2018 Results, Revises…
|
French | 1.0 MB | ||
| 2018-06-18 22:31 |
Lilly Declares Third-Quarter 2018 Dividend
|
French | 182.7 KB | ||
| 2018-06-18 20:53 |
Eli Lilly and Company: Eli Lilly and Company Files a Form 11-K
|
English | 9.8 KB | ||
| 2018-06-12 08:05 |
Update on Phase 3 Clinical Trials of Lanabecestat for Alzheimer's Disease
|
French | 277.9 KB | ||
| 2018-06-01 18:12 |
Eli Lilly and Company: FDA Approves OLUMIANT(R) (baricitinib) 2-mg Tablets for …
|
French | 191.9 KB | ||
| 2018-05-23 20:10 |
Sue Mahony to Retire as President of Lilly Oncology
|
English | 3.7 KB | ||
| 2018-05-17 22:19 |
Eli Lilly and Company Files a Form 8-K
|
English | 1.5 KB | ||
| 2018-05-14 13:53 |
Lilly to Acquire AurKa Pharma
|
English | 7.1 KB | ||
| 2018-05-11 19:00 |
Lilly to Participate in UBS Global Healthcare Conference
|
English | 2.1 KB | ||
| 2018-05-10 13:30 |
Lilly Announces Agreement To Acquire ARMO BioSciences
|
English | 12.9 KB | ||
| 2018-05-09 01:05 |
Eli Lilly and Company: Form 8-K
|
English | 607 bytes | ||
| 2018-05-09 01:05 |
Eli Lilly and Company: Form 8-K
|
English | 44.6 KB | ||
| 2018-05-09 01:02 |
Eli Lilly and Company Files a Form 8-K
|
English | 1.6 KB | ||
| 2018-05-08 00:04 |
Lilly Declares Second-Quarter 2018 Dividend
|
English | 1.8 KB |
Automate Your Workflow. Get a real-time feed of all ELI LILLY & Co filings delivered via API.
Market Data
Market Data Not Available
Financials & KPIs
Unlock Full Financials for ELI LILLY & Co
This data is available as part of our premium data solutions. Contact our team for access.
Need More History? Access decades of standardized financials for ELI LILLY & Co via our API.
Insider Transactions
| Date | Insider Name | Position | Type | Shares | Value |
|---|---|---|---|---|---|
| No insider transactions recorded for this company. | |||||
Peer Companies
